BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23515489)

  • 1. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities.
    Monroig PD; Calin GA
    Curr Pathobiol Rep; 2013 Mar; 1(1):43-52. PubMed ID: 23515489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIRCULATING microRNAs: POTENTIAL BIOMARKERS IN CANCER DETECTION, DIAGNOSIS AND PROGNOSIS.
    Makarem N; Mourad A; Nassar FJ; Nasr R
    J Med Liban; 2016 Aug; 64(2):116-122. PubMed ID: 30452151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding landscapes of colorectal cancer.
    Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
    World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer.
    Guo T; Li J; Zhang L; Hou W; Wang R; Zhang J; Gao P
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):31-48. PubMed ID: 30417217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions.
    Catalanotto C; Cogoni C; Zardo G
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free microRNAs as biomarkers for colorectal cancer.
    Toiyama Y; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Surg Today; 2016 Jan; 46(1):13-24. PubMed ID: 25712224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
    Novak J; Souček M
    Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of circulating non-coding RNAs - an update.
    Anfossi S; Babayan A; Pantel K; Calin GA
    Nat Rev Clin Oncol; 2018 Sep; 15(9):541-563. PubMed ID: 29784926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review.
    Mohan Lal P; Hamza Siddiqui M; Soulat A; Mohan A; Tanush D; Tirath K; Raja S; Khuzzaim Khan M; Raja A; Chaulagain A; Tejwaney U
    Ann Med Surg (Lond); 2024 Jun; 86(6):3543-3550. PubMed ID: 38846828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
    Gao Z; Fu P; Yu Z; Zhen F; Gu Y
    Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating cell-free microRNAs as clinical cancer biomarkers.
    Armand-Labit V; Pradines A
    Biomol Concepts; 2017 May; 8(2):61-81. PubMed ID: 28448269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.